title: High Added Value - but Many Stumbling Blocks along the Way NTN Biotech Identifies where the Shoe Pinches.
abstract: The year 1958, when DNA was first made in a test tube, marked the birth of modern biotechnology. DNA has now developed into an important technology that makes a key contribution in various sectors such as agriculture, environment and cleansing, and it has triggered a veritable boom in medicine. Today, biologics account for more than 60% of newly approved drugs. They are efficient, save time and money and have few or minimal side effects, fuelling the appetite of big pharma to take over biotech companies. Where will the journey lead?
authors.affiliation: Journalist science + technology.
authors.forename: Elsbeth
authors.initials: E
authors.lastname: Heinzelmann
mesh_terms: D001709:Biotechnology / Q000191:economics / Q000331:legislation & jurisprudence / Q000639:trends*; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence / Q000639:trends; D017048:Health Care Costs